This company develops advanced in vitro skin organoids for pharmaceutical and dermo-cosmetic industries. They provide biobank access to customizable organoids and offer disease modeling for genetic and inflammatory conditions, enabling businesses to enhance compound analysis reliability.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional methods of compound analysis in the pharmaceutical and dermo-cosmetic industries often lack the biological complexity needed to accurately predict efficacy and toxicity in human skin. Animal models raise ethical concerns and may not fully replicate human skin responses, while conventional in vitro models often lack the multi-cellular interactions necessary for comprehensive analysis.
Solution
BioHive provides advanced, customizable in vitro skin organoids that offer a more reliable and biologically relevant platform for compound analysis. Derived from induced pluripotent stem cells (iPSCs), these organoids contain multiple skin cell types, including epidermis, dermis, hair follicles, neurons, and adipocytes, enabling the study of cell-cell interactions and inflammatory signatures. BioHive's technology allows for disease modeling of genetic and inflammatory skin conditions and targeted research for focused efficacy analysis. These skin organoids enhance the robustness of research outcomes, reduce reliance on animal models, and accelerate the development of new pharmaceutical and dermo-cosmetic products.
Target Audience
BioHive's primary customers are in the pharmaceutical and dermo-cosmetic industries, including researchers and product developers focused on skin-related drug discovery, toxicity testing, and cosmetic ingredient development.
Features
- Skin organoids derived from induced pluripotent stem cells (iPSCs) for unlimited cell source and reproducibility
- Inclusion of multiple cell types: epidermis, dermis, hair follicles, neurons, and adipocytes
- Customizable organoids to suit specific biological needs
- Disease modeling capabilities for genetic and inflammatory conditions
- 3D imaging for detailed analysis of organoid structure and function
- Efficacy and toxicity analysis
- Analysis of cell-cell interactions and inflammatory signatures